InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Weis Holger. Officer active across 2 companies, notably Ziopharm Oncology INC. In total, 5 disclosures have been logged. Total volume traded: €155k. The latest transaction was disclosed on 22 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
040,000 shares0
Common Stock
SEC:0000899243-22-023977:0·
€77,27450,000 shares@ €1.5455100.0% of flow
Common Stock
SEC:0001209191-21-054828·
Ideal exit: 29 May 2022 (T+270)
€77,27450,000 shares@ €1.545550.0% of flow
Common Stock
SEC:0001209191-21-054828:0·
Ideal exit: 29 May 2022 (T+270)
04,167 shares0
Common Stock
SEC:0001209191-21-030746·
04,167 shares0
Common Stock
SEC:0001209191-21-030746:0·
5 of 5 declarations
About Weis Holger
Weis Holger is a director at Ziopharm Oncology INC and Alaunos Therapeutics, Inc.
